Embla Medical hf. (OSSUY)

Market Cap	1.71B -6.8%
Revenue (ttm)	928.69M +8.6%
Net Income	83.34M +22.1%
EPS	0.20 +22.0%
Shares Out	n/a
PE Ratio	20.48
Forward PE	16.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	425
Open	3.815
Previous Close	n/a
Day's Range	3.815 - 3.815
52-Week Range	3.670 - 5.610
Beta	0.43
RSI	42.97
Earnings Date	Apr 28, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides os...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,195
• Stock Exchange: OTCMKTS
• Ticker Symbol: OSSUY

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.